Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2201 - 2225 of 2809 in total
INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.
Investigational
Experimental
Illicit
Experimental
Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Investigational
Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. Edivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012.
Investigational
Matched Categories: … Alcohols
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
Investigational
IPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Investigational
Delpazolid (LCB01-0371) is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
Investigational
Bamifylline is a selective A1 adenosine receptor antagonist.
Experimental
Metrizamide is a solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.
Experimental
Experimental
Displaying drugs 2201 - 2225 of 2809 in total